Alpha Emitter Market, By Type of Radionuclide (Radium (Ra-223), Actinium (Ac-225), and Lead (Pb-212)), By Medical Applications (Prostate Cancer, Bone Metastases, Ovarian Cancer, Pancreatic Cancer, Endocrine Tumors, and Other Medical Applications), and By

Alpha Emitter Market, By Type of Radionuclide (Radium (Ra-223), Actinium (Ac-225), and Lead (Pb-212)), By Medical Applications (Prostate Cancer, Bone Metastases, Ovarian Cancer, Pancreatic Cancer, Endocrine Tumors, and Other Medical Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Alpha emitters play a significant role in the treatment of different types of cancer. Targeted alpha therapy (TAT) is a therapeutic option in patients with multiple micro-metastases. Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancer. Properties of alpha emitters have led to exert profound differences between this field and other fields of nuclear medicine.

Market Dynamics:

Increase in burden of cancer, rise in geriatric population, increase in use of targeted alpha therapy (TAT) for cancer treatment, rise in awareness about the potential benefits of TAT, and increase in research and development are expected to propel the growth of the global alpha emitter market.

For instance, in July 2021, Alpha Tau Medical Ltd. and Healthcare Capital Corporation signed an agreement to further expand Alpha Tau's clinical strategy, including the pursuit of FDA (Food and Drug Administration) marketing authorization, a broad array of R&D (research and development) activities, expanding manufacturing capacity, and preparing for commercialization.

Key features of the study:

  • This report provides in-depth analysis of the global alpha emitter market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global alpha emitter market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Bayer AG, Alpha Tau Medical Ltd., Fusion Pharmaceuticals, Telix Pharmaceuticals, Orano Group (Orano Med), NOVARTIS AG (Endocyte Inc.), and Actinium Pharmaceutical Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global alpha emitter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alpha emitter market.
Detailed Segmentation:
  • Global Alpha Emitter Market, By Type of Radionuclide:
  • Radium (Ra-223)
  • Actinium (Ac-225)
  • Lead (Pb-212)
  • Global Alpha Emitter Market, By Medical Applications:
  • Prostate Cancer
  • Bone Metastases
  • Ovarian Cancer
  • Pancreatic Cancer
  • Endocrine Tumors
  • Other Medical Applications
  • Global Alpha Emitter Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
  • Company Profiles:
  • Bayer AG
  • Alpha Tau Medical Ltd.
  • Fusion Pharmaceuticals
  • Telix Pharmaceuticals Ltd.
  • Orano Group (Orano Med)
  • NOVARTIS AG (Endocyte Inc.)
  • Actinium Pharmaceutical Inc.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type of Radionuclide
Market Snapshot, By Medical Applications
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Rise in burden of cancer and rise in geriatric population
Stringent regulations and need for high capital investment
Increase in adoption/use of targeted alpha therapy (TAT)
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Alpha Emitter Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Alpha Emitter Market, By Type of Radionuclide, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Radium (Ra-223)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Actinium (Ac-225)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Lead (Pb-212)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
6. Global Alpha Emitter Market, By Medical Applications, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Prostate Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Bone Metastases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Ovarian Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Pancreatic Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Endocrine Tumors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Other Medical Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
7. Global Alpha Emitter Market, By Geography, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Middle East and Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Rest of World
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
8. Competitive Landscape
Bayer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Alpha Tau Medical Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Fusion Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Telix Pharmaceuticals Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Orano Group (Orano Med)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
NOVARTIS AG (Endocyte Inc.)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Actinium Pharmaceutical Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
9. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Alpha Emitter Market” - forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings